GPAS 2025: Shaping the Future of Bleeding Disorder Care
The World Federation of Hemophilia (WFH) recently shared an insightful post on X:
”At GPAS 2025, global experts explored the evolving treatment landscape for bleeding disorders—highlighting innovations in hemophilia and VWD care, and addressing challenges in access and reimbursement. A timely look at what’s ahead in care.”
At GPAS 2025, leading global experts Jamie O’Hara, Alok Srivastava, Nathan Connell and Cedric Hermans convened to discuss the rapidly evolving treatment landscape for bleeding disorders.
Sessions spotlighted innovation in hemophilia and von Willebrand disease (VWD) care, including novel therapeutics, personalized medicine, and gene-based approaches.
Critical dialogue also addressed ongoing challenges in access, affordability, and reimbursement.
The meeting offered a timely and forward-looking perspective on the future of equitable care delivery!
Find more footage from the webinar in the gallery.
Hemostasis Today, your daily update on the World of Hemophilia.
-
Oct 9, 2026, 11:06Nobles Green: How siRNA Therapy Helps the Body Form Stronger Clots
-
Oct 9, 2026, 10:53Switching From Emicizumab to Denecimig in Hemophilia A – Rare Disease Advisor
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient
-
Oct 9, 2026, 07:21Federico Ravaioli: 40 kPa Spleen Stiffness May Help Avoid Endoscopy in Chronic PVT